SGARABOTTO, LUCA

SGARABOTTO, LUCA  

Università di Padova  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A Continuous Renal Replacement Therapy Protocol for Patients With Acute Kidney Injury in Intensive Care Unit With COVID-19 2020 Federico NalessoLeda CattarinLaura GobbiLaila QassimLuca SgarabottoLorenzo A Calò + JOURNAL OF CLINICAL MEDICINE - -
ACE2 and prognosis of COVID-19. Insights from Bartter's and Gitelman's syndromes patients. 2020 Calò LARigato MSgarabotto L. + JOURNAL OF MEDICAL VIROLOGY - -
ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman’s and Bartter’s Syndromes. 2021 Lorenzo A. CalòMatteo RigatoLuca SgarabottoLisa GianeselloGiovanni BertoldiVerdiana Ravarotto + FRONTIERS IN MEDICINE - -
Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter’s and Gitelman’s syndromes patients. 2020 Lorenzo A CalòMatteo RigatoLuca Sgarabotto + JOURNAL OF HYPERTENSION - -
COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection. 2022 Calò LASgarabotto LStefanelli LFDi Vico V + JN. JOURNAL OF NEPHROLOGY - -
Impaired ACE2 glycosylation and protease activity in Fabry disease protects from COVID-19. 2023 Caputo IBertoldi GSgarabotto LStefanelli LFCalò LA. + JOURNAL OF INTERNAL MEDICINE - -
Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman’s and Bartter’s syndromes 2024 SGARABOTTO, LUCA - - -
Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman’s and Bartter’s syndromes. 2021 Giovanni BertoldiLuca SgarabottoLorenzo A Calò + JOURNAL OF INTERNAL MEDICINE - -
Is increased rho kinase activity/oxidative stress relationship the missing link for linezolid-induced thrombocytopenia in dialysis patients? 2021 Sgarabotto LCalò LA. + INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS - -
Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes 2023 Luca SgarabottoLucia Federica StefanelliFederico NalessoLorenzo A. Calò + ANTIOXIDANTS - -
Rare genetic tubulopathies Gitelman's and Bartter's syndromes and their naturally occurring protection from COVID-19. 2022 Sgarabotto LucaGianesello LisaBertoldi GiovanniNalesso FedericoStefanelli Lucia FedericaCalò Lorenzo. MINERVA MEDICA - -
SARCOIDOSIS: HOW ITS DIAGNOSIS MIGHT REVEAL TROUBLED 2019 Maria Loreta De GiorgiSGARABOTTO, LUCAMonica SimeoneBONELL, VERAValeria MaffeisFederico NalessoLorenzo A Calò + ACTA MEDICA MEDITERRANEA - -